Pluripotent Stem Cell-Derived Therapies for the Treatment of Autoimmune Diseases

Autoimmune diseases involve dysregulation of one or more aspects of a patient’s immune system, often leading to inflammation that can ultimately result in irreversible tissue and organ damage.

Our scientists developed a method for treating autoimmune and inflammatory diseases by engineering pluripotent stem cells to create cell therapies that can restore the function of the immune system¹⁷.

Pluripotent Stem Cell-Derived Therapies for the Treatment of Autoimmune Diseases is protected by a pending U.S. patent (with additional patents pending in other countries).

• Target neurodegenerative and inflammatory diseases using immunomodulatory pluripotent stem cell-derived therapies
• Combine with Factor’s Combined mRNA Cell Reprogramming & Gene Editing for streamlined manufacturing

• Combine with Factor’s Gene-Edited Allogeneic Cell Therapies Technology to create “off-the-shelf” therapies